house · trading 2018-06-28 → 2022-11-17
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2022-11-17 | GS | BUY | $15K–$50K | $379.78 | $1042.63 2026-08-13 | +174.5% |
| 2018-06-28 | GSK | SELL | $1K–$15K | $39.57 | $50.45 2026-08-13 | -27.5% exit |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Thomas H Tuberville | 2 · GSK, GS |
| Thomas R Carper | 2 · GSK, GS |
| John Boozman | 2 · GSK, GS |
| David P. Roe | 2 · GSK, GS |
| Mike Kelly | 2 · GSK, GS |
| Pete Sessions | 2 · GSK, GS |
| Katherine M. Clark | 2 · GSK, GS |
| Marjorie Taylor Mrs Greene | 2 · GSK, GS |
| Zoe Lofgren | 2 · GSK, GS |
| David Kustoff | 2 · GSK, GS |
| James B. Renacci | 1 · GSK |
| Alan S. Lowenthal | 1 · GS |